Calon et al. [174] demonstrated that increased stromal TGF-β signaling significantly promoted CRPM and CRLM in murine models through the upregulation of GP130–p-STAT3 signaling in CRC cells. This evidence concerns the gene SH3BP2 and colorectal carcinoma.